Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Albumin in Malignancy-Related Ascites Paracentesis
NCT02811406Unknown
- Sponsor
- National University Hospital
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of albumin (human) in malignant ascites (2 arms), sponsored by National University Hospital. Primary endpoint: Rates of hypotension at 48 hours. Status: unknown.
02
Drugs
albumin (human)
03
Conditions
malignant ascites
Beyond the preview
Go deeper on NCT02811406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02811406.